Behind the paper: high-throughput screening in dermatology

About this Podcast

From a workflow perspective, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary. Recent studies suggest that pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Emerging evidence indicates that standardized reporting improves comparability between centers, although confirmatory data are still limited. Longitudinal data show that training and accreditation are decisive for reproducibility, pending validation in prospective studies. Emerging evidence indicates that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies. When protocols are compared, early intervention correlates with better long-term outcomes, and this trend is expected to continue.